Semaphorin 3G (SEMA3G) is a highly selective marker of cerebral amyloid angiopathy
Kaleah Balcomb, Jessica Buchanan, Aysha Y. G. Strobbe, Daphne Claus, Arline Faustin, J. S. Schneider, Thomas Wısnıewskı, Margaret Sunde, Eleanor Drummond
The paper identifies SEMA3G as a specific marker for cerebral amyloid angiopathy (CAA) through analysis of human brain tissue and demonstrates its interaction with specific amyloid beta variants.
bioRxiv · Sep 16, 2026 · PreprintNeuroscience